Ticker
KALVCompany Name
KALVISTA PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -186.69M | $ -3.49 | 1 | 53.5M |
3/31/2025 | $ -172.96M | $ -3.48 | 1 | 49.65M |
12/31/2024 | $ -167.88M | $ -3.19 | 1 | 52.64M |
9/30/2024 | $ -155.51M | $ -3.33 | 1 | 46.7M |
6/30/2024 | $ -140.94M | $ -3.05 | 1 | 46.23M |
3/31/2024 | $ -125.84M | $ -3.42 | 1 | 36.79M |
12/31/2023 | $ -107.49M | $ -3.1 | 1 | 34.72M |
9/30/2023 | $ -99.77M | $ -2.89 | 1 | 34.57M |
6/30/2023 | $ -94.36M | $ -2.74 | 1 | 34.41M |
3/31/2023 | $ -92.11M | $ -3.3 | 1 | 27.89M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for KALVISTA PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -36.96M ] / (Shares WA [ 17.91M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -2.06 ]
Minimum
Sep 30, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -10.86 |
max | $ 13.95 |
average | $ 2.01 |
median | $ 0.99 |
std | $ 4.26 |